|
2DM1
Solution structure of the second SH3 domain of human protein vav-2
Deposited 2006-04-20
|
Different construct
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
819–878(60 aa)
Fragment:sh3 domain
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1.07mM 13C,15N-labeled protein; 20mM d-Tris-HCl(pH7.0); 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 90% H2O; 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2LNW
Identification and structural basis for a novel interaction between Vav2 and Arap3
Deposited 2012-01-05
|
Different construct
Different oligomeric state
Different experimental conditions
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
659–771(113 aa)
Fragment:UNP RESIDUES 659-771
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.2;298 K;Ionic strength (raw mmCIF value) 120;Pressure ambient
NMR sample composition
1 mM [U-100% 13C; U-100% 15N] entity_1-1, 3 mM entity_2-2, 5 mM potassium phosphate-3, 20 mM sodium phosphate-4, 5 mM DTT-5, 2 mM EDTA-6, 75 mM sodium chloride-7, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1 mM [U-100% 13C; U-100% 15N] entity_1-8, 3 mM entity_2-9, 5 mM potassium phosphate-10, 75 mM sodium chloride-11, 5 mM DTT-12, 2 mM EDTA-13, 20 mM sodium phosphate-14, 100% D2O | 100% D2O
|
Resolution not provided
|
|
2LNX
Solution structure of Vav2 SH2 domain
Deposited 2012-01-05
|
Different construct
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
659–771(113 aa)
Fragment:UNP RESIDUES 659-771
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.2;293 K;Ionic strength (raw mmCIF value) 120
NMR sample composition
1 mM [U-13C; U-15N] entity-1, 5 mM DTT-2, 75 mM sodium chloride-3, 5 mM potassium phosphate-4, 20 mM sodium phosphate-5, 1 mM EDTA-6, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1 mM [U-13C; U-15N] entity-7, 75 mM sodium chloride-8, 5 mM DTT-9, 5 mM potassium phosphate-10, 20 mM sodium phosphate-11, 1 mM EDTA-12, 100% D2O | 100% D2O
|
Resolution not provided
|
|
4ROJ
Crystal Structure of the VAV2 SH2 domain in complex with TXNIP phosphorylated peptide
Deposited 2014-10-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
667–782(116 aa)
Fragment:UNP residues 667-782
|
Not recorded
|
UNX UNKNOWN LIGAND × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;30% PEG550-MME, 0.1 M ammonium sulfate, 0.1 M cacodylate pH 6.5, vapor diffusion, sitting drop, temperature 293K
|
Resolution 1.95 Å
R-free 0.219
|
|
4ROJ
Crystal Structure of the VAV2 SH2 domain in complex with TXNIP phosphorylated peptide
Deposited 2014-10-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
667–782(116 aa)
Fragment:UNP residues 667-782
|
Not recorded
|
UNX UNKNOWN LIGAND × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;30% PEG550-MME, 0.1 M ammonium sulfate, 0.1 M cacodylate pH 6.5, vapor diffusion, sitting drop, temperature 293K
|
Resolution 1.95 Å
R-free 0.219
|
|
4ROJ
Crystal Structure of the VAV2 SH2 domain in complex with TXNIP phosphorylated peptide
Deposited 2014-10-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
667–782(116 aa)
Fragment:UNP residues 667-782
|
Not recorded
|
UNX UNKNOWN LIGAND × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;30% PEG550-MME, 0.1 M ammonium sulfate, 0.1 M cacodylate pH 6.5, vapor diffusion, sitting drop, temperature 293K
|
Resolution 1.95 Å
R-free 0.219
|
|
7RNV
SH2 domain of guanine nucleotide exchange factor Vav2 in complex with an actin peptide with phosphorylated tyrosine 53
Deposited 2021-07-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
665–774(110 aa)
Fragment:SH2 domain (UNP residues 665-774)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;292 K;0.2 M sodium acetate trihydrate, 0.1 M Tris hydrochloride, pH 8.5, 30% PEG4000
|
Resolution 2.15 Å
R-free 0.272
|
|
7WFY
Crystal Structure of the VAV2 SH2 domain in complex with APP phosphorylated peptide
Deposited 2021-12-27
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
659–771(113 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.4;289 K;25% PEG 3350, 0.2 M Magnesium chloride hexahydrate, 0.1 M, Tris/HCl, pH 8.4
|
Resolution 2.45 Å
R-free 0.268
|